Nuvo Pharmaceuticals (OTCMKTS:NRIFF) Stock Price Down 7.5%

Nuvo Pharmaceuticals Inc (OTCMKTS:NRIFF)’s stock price was down 7.5% during mid-day trading on Thursday . The stock traded as low as $0.36 and last traded at $0.39, approximately 2,900 shares were traded during trading. A decline of 51% from the average daily volume of 5,901 shares. The stock had previously closed at $0.42.

The company has a debt-to-equity ratio of 5.63, a quick ratio of 1.50 and a current ratio of 2.12. The company has a 50-day moving average of $0.36 and a 200 day moving average of $0.47.

Nuvo Pharmaceuticals (OTCMKTS:NRIFF) last issued its quarterly earnings results on Thursday, October 31st. The company reported $0.01 earnings per share (EPS) for the quarter. Nuvo Pharmaceuticals had a negative return on equity of 43.73% and a negative net margin of 1.56%. The firm had revenue of $14.26 million during the quarter.

Nuvo Pharmaceuticals Company Profile (OTCMKTS:NRIFF)

Nuvo Pharmaceuticals Inc, a commercial healthcare company, produces and sells pharmaceutical products in the United States, Canada, and Europe. It offers Pennsaid, a topical pain product that is used to treat the signs and symptoms of osteoarthritis of the knee; Pennsaid 2%, a follow-on product to Pennsaid for the treatment of the pain of osteoarthritis of the knee; Heated Lidocaine/Tetracaine (HLT) Patch, a topical patch that provides local analgesia prior to painful needle procedures, such as dialysis, blood draws, and pediatric needles; and Resultz, an over-the-counter product intended to kill head lice and remove their eggs from hair.

Further Reading: Producer Price Index (PPI)

Receive News & Ratings for Nuvo Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuvo Pharmaceuticals and related companies with's FREE daily email newsletter.